The FDA backs off a hasty — and damaging — emergency OK for a potentially dangerous Covid-19 drug
The FDA rushed in with an emergency authorization less than 3 months ago to allow anxious, frightened people the opportunity of using two malaria drugs to ward off Covid-19. One of them, hydroxychloroquine, arrived with the repeated endorsement of President Donald Trump — who ended up taking it himself — and various Fox News commentators. But with the evidence of its uselessness for guarding against coronavirus growing, as data on potential safety risks mounted amid a chorus of expert warnings, the agency reversed itself on Monday and revoked the green light.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.